Crossmark

Comparison of Innovator vs. Biosimilar Ranibizumab in Treating Diabetic Macular Edema: A Multicenter Retrospective Study

Published Online: 2022-01-24

Published Print: 2022-04

Authors

Chakraborty, Debdulal https://orcid.org/0000-0001-9693-7882
Sengupta, Sabyasachi

Mondal, Soumen

Boral, Subhendu

Das, Arnab

Sinha, Tushar Kanti

Bhattacharya, Ranabir

Maitra, Ritobroto
License Information

Text and Data Mining valid from 2022-01-24

Version of Record valid from 2022-01-24
More Information

Article History

Received: 18 December 2021

Accepted: 11 January 2022

First Online: 24 January 2022

Document is current